Latest News about ABT
Recent news which mentions ABT
The 7 Most Undervalued Dividend Aristocrats to Buy
February 13, 2023
From InvestorPlace
Abbott-Cardiovascular Systems Acquisition Could Further Add Uncertainty Over Surmodics' Product: Analyst Downgrades Stock
February 13, 2023
From Benzinga
Why Cardiovascular Systems Stock Is Soaring Today
February 09, 2023
From Motley Fool
Why Is Cardiovascular Systems (CSII) Stock Up 48% Today?
February 09, 2023
From InvestorPlace
Abbott Adds Complementary Technologies To Its Vascular Offering Via Cardiovascular Systems Deal For $890M
February 09, 2023
From Benzinga
3 Dividend Stocks That Will Hold Up No Matter the Market Conditions
February 08, 2023
From Motley Fool
Baby Formula Blues Hit Abbott Laboratories Stock Hard in 2022. Can It Rebound in 2023?
February 07, 2023
Tickers
ABT
From Motley Fool
2 Beaten-Down Stocks With Stable Dividends to Buy In 2023
February 04, 2023
From Motley Fool
3 Unstoppable Dividend Stocks to Buy in February
February 04, 2023
From Motley Fool
2 Top Dividend Growth Stocks to Buy in February
February 01, 2023
From Motley Fool
Quant Ratings Updated on 105 Stocks
January 31, 2023
From InvestorPlace
5 Top Stocks to Buy Now
January 31, 2023
From Motley Fool
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
January 28, 2023
From Motley Fool
What 5 Analyst Ratings Have To Say About Abbott Laboratories
January 26, 2023
Tickers
ABT
From Benzinga
From Benzinga
Abbott's Sales and Earnings Are Sinking: Should Investors Worry?
January 26, 2023
Tickers
ABT
From Motley Fool
Why Abbott Laboratories Stock Got Whacked on Wednesday
January 25, 2023
Tickers
ABT
From Motley Fool
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
January 25, 2023
Tickers
ABT
From Motley Fool
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
January 25, 2023
Tickers
ABT
From Benzinga
Why Aurora Cannabis Stock Is Fading Today
January 25, 2023
From Motley Fool
From Benzinga
China’s Lunar New Year celebrations raise concerns about COVID spread, while officials say peak is past
January 25, 2023
From MarketWatch
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
January 25, 2023
From Benzinga
From MarketWatch
Earnings Scheduled For January 25, 2023
January 25, 2023
From Benzinga
Investor Optimism Declines Following Earnings Reports
January 25, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.